\
&
Contact us
\
&
Contact us
Published on | 4 years ago
Programmes Food Green DealAre you still looking for consortium partners to submit a project for the Green Deal? Then this Partnership profiles catalogue H2020 Green Deal call - LC-GD-1-6-2020 might be useful to find these partners:
This Catalogue has been developed by the Enterprise Europe Network (E.E.N.) – AgroFood Sector Group. Its main aim is to encourage the Participation of SMEs, R&D Institutions and Technology Centres in the topic LC-GD-6-1-2020: “Testing and demonstrating systemic innovations in support of the Farm-to-Fork Strategy” from Green Deal call of Horizon2020 Programme.
The entities behind those profiles are known by the members of Enterprise Europe Network and are therefore reliable.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Health Culture and society Security Digital, Industry & Space
The open and forthcoming calls under Horizon Europe have been published on the Funding & Tenders Portal (Funding - Call for proposals) However, there are technical issues with the filter functions in Pillar 2: filtering per cluster does not display all 2025 call topics within this cluster and advertise call topics of other work programmes. The... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
